Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0YZ1B
|
|||
| Drug Name |
PMID25468267-Compound-50
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
EPITHERAPEUTICS APS
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H16N4O2
|
|||
| Canonical SMILES |
C1=CN=C(C=C1C(=O)O)CNCCCN2C=CN=C2
|
|||
| InChI |
1S/C13H16N4O2/c18-13(19)11-2-4-16-12(8-11)9-14-3-1-6-17-7-5-15-10-17/h2,4-5,7-8,10,14H,1,3,6,9H2,(H,18,19)
|
|||
| InChIKey |
HGXLVPBZRFKRHK-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lysine-specific demethylase 4 (KDM4) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Lysine-specific demethylase 4 (KDM4) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.